Browse

You are looking at 1 - 10 of 3,717 items for

  • Refine by Content Type: All x
Clear All Modify Search

After a year-long investigation, the House of Representatives Committee on Ways and Means found “there is a need and desire for professional medical societies to lead the way in a critical reexamination of how race and ethnicity data, when used improperly…can create worse outcomes for patients of color.”

JASN, CJASN, and Kidney360 recently honored their top five reviewers of 2021. Reviewers play an important role in the process of peer-review and are key to the success of ASN journals.

Priority #4: ACHIEVE EQUITY and eliminate disparities. Health disparities and the incidence of kidney diseases are undoubtedly connected. We need to address disparities and achieve equity not just in kidney care, but in health care overall.

ASN continues to support the need to address equity in the End-Stage Renal Disease (ESRD) Treatment Choices Model and approve the first device for add-on innovation payment in kidney care. 

A team of surgeons at NYU Langone Health in New York have transplanted a pig kidney into a human patient without triggering immediate rejection by the recipient’s immune system.

Priority #3: ACCELERATE INNOVATION and expand patient choice. We need to develop future leaders in nephrology who can move the field forward scientifically and serve as advocates for our patients and our specialty.

In a joint statement, the American Society of Nephrology, European Renal Association, and International Society of Nephrology discuss the state of the global nephrology workforce.

Priority #2: TRANSFORM TRANSPLANT and increase access to donor kidneys. If patients understood the benefits of transplantation and the process involved, more would likely accept the opportunity and pursue transplant listing.

ASN joined several other health care professional societies in a meeting with the White House Domestic Policy Council and Office of Public Engagement to discuss clinical labor direct cost issues updates (as announced in the proposed CY 2022 Medicare Physician Fee Schedule (MPFS) rule) and its potential impact to patient care.

Priority #1: INTERVENE EARLIER to prevent, diagnose, coordinate care, and educate. The scope of early intervention is so expansive that it touches every aspect of kidney health.